$4.40
0.051.15%
Pre-Market: 7:33 AM EDT
Comments
Loading...
Karyopharm Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:KPTI | Benzinga
Karyopharm Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-3.000
Quarterly Revenue Estimate
$45.71M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$145.24M
Analyze the earnings history of Karyopharm Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics | -$4.80 | -$3.00 | — | — | $33.13M | $45.71M | — | — | 05/07/2025 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$5.40 | -$4.05 | -$3.60 | 11.11% | $33.75M | $35.67M | $30.54M | -14.38% | 02/19/2025 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$4.50 | -$3.90 | -$3.90 | 0.00% | $36.01M | $37.79M | $38.78M | 2.63% | 11/05/2024 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$4.35 | -$4.50 | -$3.00 | 33.33% | $37.58M | $36.18M | $42.79M | 18.26% | 08/06/2024 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$4.50 | -$4.95 | -$4.80 | 3.03% | $38.70M | $34.47M | $33.13M | -3.90% | 05/08/2024 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$6.45 | -$4.65 | -$5.40 | -16.13% | $33.58M | $35.40M | $33.75M | -4.67% | 02/29/2024 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$6.75 | -$4.20 | -$4.50 | -7.14% | $36.15M | $37.28M | $36.01M | -3.41% | 11/02/2023 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$9.30 | -$5.10 | -$4.35 | 14.71% | $39.68M | $36.23M | $37.58M | 3.72% | 08/02/2023 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$7.95 | -$5.55 | -$4.50 | 18.92% | $47.67M | $36.60M | $38.70M | 5.73% | 05/04/2023 | Get Alert |
| KPTI | Karyopharm Therapeutics | $6.90 | -$5.25 | -$6.45 | -22.86% | $126.27M | $35.12M | $33.58M | -4.38% | 02/15/2023 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$10.35 | -$8.55 | -$6.75 | 21.05% | $37.69M | $34.56M | $36.15M | 4.59% | 11/03/2022 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$10.65 | -$9.45 | -$9.30 | 1.59% | $22.60M | $35.59M | $39.68M | 11.49% | 08/04/2022 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$11.55 | -$9.45 | -$7.95 | 15.87% | $23.26M | $34.17M | $47.67M | 39.51% | 05/05/2022 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$8.85 | -$7.35 | $6.90 | 193.88% | $35.10M | $50.49M | $126.27M | 150.09% | 02/08/2022 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$10.95 | -$10.05 | -$10.35 | -2.99% | $21.33M | $25.80M | $37.69M | 46.08% | 11/03/2021 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$9.45 | -$11.10 | -$10.65 | 4.05% | $33.51M | $25.64M | $22.60M | -11.85% | 08/05/2021 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$11.70 | -$10.65 | -$11.55 | -8.45% | $18.14M | $25.17M | $23.26M | -7.59% | 05/03/2021 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$11.40 | -$0.59 | -$8.85 | -1400.00% | $18.10M | $29.37M | $35.10M | 19.51% | 02/11/2021 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$10.05 | -$10.80 | -$10.95 | -1.39% | $13.15M | $21.45M | $21.33M | -0.55% | 11/02/2020 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$10.65 | -$8.70 | -$9.45 | -8.62% | $9.49M | $27.42M | $33.51M | 22.22% | 08/04/2020 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$16.35 | -$10.35 | -$11.70 | -13.04% | $155.00K | $21.28M | $18.14M | -14.77% | 05/05/2020 | Get Alert |
Karyopharm Therapeutics (KPTI) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-19 | $-3.60 | $-4.05 | 11.1 % |
| Q3 | 2024-11-05 | $-3.90 | $-3.90 | 0.00 % |
| Q2 | 2024-08-06 | $-3.00 | $-4.50 | 33.3 % |
| Q1 | 2024-05-08 | $-4.80 | $-4.95 | 3.03 % |
Karyopharm Therapeutics (KPTI) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-19 | $30.54M | $35.67M | -14.4 % |
| Q3 | 2024-11-05 | $38.78M | $37.79M | 2.63 % |
| Q2 | 2024-08-06 | $42.79M | $36.18M | 18.3 % |
| Q1 | 2024-05-08 | $33.13M | $34.47M | -3.90 % |
FAQ
When is Karyopharm Therapeutics (NASDAQ:KPTI) reporting earnings?
Karyopharm Therapeutics (KPTI) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on February 19, 2025 for Q4.
What were the latest earnings per share (EPS) for Karyopharm Therapeutics (NASDAQ:KPTI)?
The Actual EPS was $-3.60, which beat the estimate of $-4.05.
What were Karyopharm Therapeutics’s (NASDAQ:KPTI) revenues?
The Actual Revenue was $30.5M, which missed the estimate of $35.7M.
Browse earnings estimates, EPS, and revenue on all stocks.